|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| G01N 33/57488 | (2013.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/513 | (2013.01) | ||
| G01N2333/49 | (2013.01) | ||
| A61K 38/179 | (2013.01) | ||
| A61K 31/4745 | (2013.01) | ||
| G01N2800/52 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3640643 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19201633.5 |
| Date of filing the European patent application | 2017-01-24 | |
| (97) | Date of publication of the European application | 2020-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 16305065 | 2016-01-25 | EP |
| (72) |
DREYMANN, Jennifer , FR
PACCARD, Caroline , FR
CHIRON-BLONDEL, Marielle , FR
|
| (73) |
Sanofi ,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER |
| METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER |